JCR Pharmaceuticals Co.,Ltd.

4552

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-07-30FY2027 Q1

Revenue

414.5100M JPY

YoY +23.7%

Operating Income

-21100M JPY

YoY -247.0%

Net Income

8.2100M JPY

YoY +115.7%

EPS

-15.6JPY

YoY -249.1%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

510.8億円

367.6億円

224.3億円

81.1億円

-62.2億円

Rev: 510.8億円Op: 199.3億円NI: 145.1億円

Rev: 343.4億円Op: 49.8億円NI: 37.7億円

Rev: 428.7億円Op: 75.3億円NI: 55.1億円

Rev: 330.7億円Op: -62.2億円NI: -44.6億円

Rev: 403.2億円Op: 5.5億円NI: 21.8億円

2022/FY2023/FY2024/FY2025/FY2026/FY

Full-Year Progress

FY2027 Q1

Net Income0%

Revenue Progress9700M

Revenue Forecast45700M

Net Income Progress-19.100M

Net Income Forecast200M

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan